Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-09 to 2025-01-24
Current total value of award: $13005.98
Description: 4566881175!ATEZOLIZMAB 60MG/ML 1S